The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Alexion Pharmaceuticals Inc

Nasdaq: ALXN
Last

(U.S.) $124.48

Today's change+1.77 +1.44%
Updated January 16 4:00 PM EST. Delayed by at least 15 minutes.
 

Alexion Pharmaceuticals Inc

Nasdaq: ALXN
Last

(U.S.) $124.48

Today's change+1.77 +1.44%
Updated January 16 4:00 PM EST. Delayed by at least 15 minutes.

Alexion Pharmaceuticals Inc up (U.S.)$1.77

Alexion Pharmaceuticals Inc closed up Tuesday by (U.S.)$1.77 or 1.44% to (U.S.)$124.48. Over the last five days, shares have gained 2.20%, but are down 9.09% for the last 52 weeks, lagging the 22.06% return in the S&P 500.

Key company metrics

  • Open(U.S.) $123.00
  • Previous close(U.S.) $122.71
  • High(U.S.) $126.06
  • Low(U.S.) $123.00
  • Bid / Ask(U.S.) $115.00 / (U.S.) $130.00
  • YTD % change+4.09%
  • Volume4,154,584
  • Average volume (10-day)2,184,076
  • Average volume (1-month)2,146,693
  • Average volume (3-month)2,028,204
  • 52-week range(U.S.) $96.18 to (U.S.) $149.34
  • Beta1.23
  • Trailing P/E55.64×
  • P/E 1 year forward21.77×
  • Forward PEG1.17×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.24
Updated January 16 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.45%Sector:HealthcareIndustry:Biotechnology

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue859912870831
Total other revenue--------
Total revenue859912870831
Gross profit702828801763
Total cost of revenue157846967
Total operating expense779686658704
Selling / general / administrative271265262260
Research & development195199219206
Depreciation / amortization80808080
Interest expense (income), net operating--------
Unusual expense (income)72342486
Other operating expenses, total42445
Operating income80226212127
Interest income (expense), net non-operating-25-24-24-25
Gain (loss) on sale of assets--------
Other--------
Income before tax58206194104
Income after tax7816517092
Income tax, total-20412412
Net income7816517092
Total adjustments to net income--------
Net income before extra. items7816517092
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items7816517092
Inc. avail. to common incl. extra. items7816517092
Diluted net income7816517092
Dilution adjustment--------
Diluted weighted average shares225225226228
Diluted EPS excluding extraordinary itemsvalue per share0.350.730.750.40
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.550.850.850.74